Recent Company News

• 03:33 PM ET Jun 12, 2026
  

  OptumRx reaches settlement with FTC on insulin pricing, withdraws from adjudication ($408.33, +2.78)

• 02:43 AM ET Jun 12, 2026
  

  StreetAccount Summary - European pre-market trading update

• 02:00 AM ET Jun 12, 2026
  

  European macro headlines:

• 02:55 PM ET Jun 10, 2026
  

  Afternoon Headlines:

• 11:34 AM ET Jun 11, 2026
  

  Novo Nordisk has identified IT security incident involving unauthorised access to limited number of internal IT systems; core business operations are not impacted and remain up and running (DKK 282.55, 0.00)

• 11:06 AM ET Jun 11, 2026
  

  Novo Nordisk's Wegovy pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK (DKK 282.55, 0.00)

• 07:03 AM ET Jun 09, 2026
  

  Novo Nordisk launches updated Rybelsus formulation in Canada for adults with Type 2 diabetes (DKK 268.40, -3.60)

• 05:50 PM ET Jun 08, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:50 AM ET Jun 08, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market